WEDINOS DAN 24/7 Public Health Wales Welsh Government Naloxone saves lives


Type Psychoactive
Legal Status Not Controlled
Selective serotonin re-uptake inhibitor (SSRI). Used for the treatment of major depression, bulimia nervosa and obsessive-compulsive disorder.
Short Term Effects
Central nervous system features include tremor, agitation, dizziness, fatigue, drowsiness, coma and convulsions. Nausea, vomiting, dilated pupils and sweating may occur. Cardiovascular features seen with SSRIs include tachycardia, hypotension, hypertension, prolongation of QT interval and QRS duration, Torsade de Pointes, and cardiac arrest.
Death Data
Death has been reported after ingestion of 6-12 g (Compton et al, 2005; Kincaid et al, 1990)